More problems for Ono's astrocyte modulator stroke programme
This article was originally published in Scrip
Executive Summary
The continued development of Ono's astrocyte modulator Arocyte (ONO-2506) has been thrown into doubt by disappointing efficacy results from a Japanese Phase II/III study in acute ischaemic stroke.